EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effectiveness of preimplantation genetic testing in sickle cell disease: insights from a single-center experience

A Aganahi, F Souare, A Mayeur, H Thomas, S Monnot, A Benachi, L Joseph, A Habibi, N Frydman, M Grynberg, J Steffann, C Sonigo

Journal of Assisted Reproduction and Genetics · 2026

DOI: 10.1007/s10815-026-03809-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Assisted Reproduction and Genetics, 2026. Verfasst von A Aganahi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Service de Médecine de La Reproduction Et Préservation de La Fertilité, AP-HP, Université Paris-Saclay, Hôpital Antoine Beclère, 157 Avenue de La Por…. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Preimplantation Diagnosis, Genetic Testing. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Université Paris-Saclay.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Sickle-cell disease (SCD) is a severe autosomal recessive disorder. At-risk couples may prevent transmission either through prenatal diagnosis with possible termination of pregnancy or preimplantation genetic testing for monogenic disease (PGT-M). Data on PGT-M outcomes in this population remain scarce.

Methods

We conducted a monocentric retrospective study (2006–2021). To assess ovarian response to stimulation, each PGT-M cycle for SCD was matched with two control cycles.

Results

Sixty couples underwent at least one ovarian stimulation for PGT procedure for SCD. Eight couples (13.3%) had one affected partner (S/S or S/C) and one carrier (A/S), while 52 couples (86.7%) were both carriers (A/S). Thirty-five couples (58.3%) already had an affected child, and 17 couples (28.3%) requested PGT-M with HLA typing. Median female age at first attempt was 33 years. Overall, 19 couples (31.7%) achieved at least one live birth following fresh or frozen embryo transfer. Among the 17 couples requesting HLA typing, three HLA-matched births (15.7%) and one unmatched healthy birth were achieved. None of the five women affected by SCD achieved a live birth. Ovarian response did not differ significantly between women with sickle cell trait and the controls.

Conclusion

PGT-M is as a viable option for obtaining healthy offspring. These results bolster the argument that PGT-M serves as an alternative to prenatal diagnosis for eligible couples. Our study aims to assist geneticists, gynecologists, and hematologists in providing the necessary guidance before embarking couples on this long and often challenging journey.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellPreimplantation DiagnosisGenetic TestingHumansFemalePregnancyAdultRetrospective StudiesMaleEmbryo TransferFertilization in VitroPregnancy RateOvulation InductionLive Birth

Stichwörter der Autor:innen

Ovarian stimulationPGT-MPreimplantation genetic diagnosisSickle cell disease

Autor:innen und Institutionen

  • Service de Médecine de La Reproduction Et Préservation de La Fertilité, AP-HP, Université Paris-Saclay, Hôpital Antoine Beclère, 157 Avenue de La Porte Trivaux, 92140, Clamart, France.
  • Service d'Histologie - Embryologie- CECOS, AP-HP, Université Paris-Saclay, Hôpital Antoine Beclère, Clamart, France.
  • Service de Médecine Génomique Des Maladies Rares, AP-HP, Hôpital Necker-Enfants Malades, Paris, France.
  • Service de Gynécologie - Obstétrique, AP-HP, Université Paris Saclay, Hôpital Antoine Béclère, Clamart, France.
  • AP-HP, Hôpital Universitaire Necker-Enfants Malades, Service Hémaphérèse Thérapeutique, Paris, France.
  • Sickle Cell Referral Center, Unité Des Maladies Génétiques du Globule Rouge, Henri MONDOR University Hospital, AP-HP, INSERM, U955, DHU A-TVB, Equipe Transfusion Et Maladies du Globule Rouge, IMRB, Creteil, France.

Förderung

  • Université Paris-Saclay

Zitieren

APA

Aganahi, A., Souare, F., Mayeur, A., Thomas, H., Monnot, S., Benachi, A., Joseph, L., Habibi, A., Frydman, N., Grynberg, M., Steffann, J., & Sonigo, C. (2026). Effectiveness of preimplantation genetic testing in sickle cell disease: insights from a single-center experience. Journal of Assisted Reproduction and Genetics. https://doi.org/10.1007/s10815-026-03809-1

Vancouver

Aganahi A, Souare F, Mayeur A, Thomas H, Monnot S, Benachi A, et al. Effectiveness of preimplantation genetic testing in sickle cell disease: insights from a single-center experience. Journal of Assisted Reproduction and Genetics. 2026. doi:10.1007/s10815-026-03809-1

BibTeX
@article{Aganahi2026,
  author = {Aganahi, A and Souare, F and Mayeur, A and Thomas, H and Monnot, S and Benachi, A and Joseph, L and Habibi, A and Frydman, N and Grynberg, M and Steffann, J and Sonigo, C},
  title = {Effectiveness of preimplantation genetic testing in sickle cell disease: insights from a single-center experience},
  journal = {Journal of Assisted Reproduction and Genetics},
  year = {2026},
  doi = {10.1007/s10815-026-03809-1}
}
Kostenlos starten →